Clinical Trial Update: To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury. [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial assessing long-term safety and efficacy of pregabalin for neuropathic pain after spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Pregabalin (Lyrica) (pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Neuropathic Pain | Phase 3 | Status: COMPLETED